BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17223629)

  • 1. Oral chemotherapy safety practices at US cancer centres: questionnaire survey.
    Weingart SN; Flug J; Brouillard D; Morway L; Partridge A; Bartel S; Shulman LN; Connor M
    BMJ; 2007 Feb; 334(7590):407. PubMed ID: 17223629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is oral chemotherapy prescription safe for patients? A cross-sectional survey.
    Bourmaud A; Pacaut C; Melis A; Tinquaut F; Magné N; Merrouche Y; Chauvin F
    Ann Oncol; 2014 Feb; 25(2):500-4. PubMed ID: 24406423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral chemotherapy practices at Ontario cancer centres.
    Ahmad N; Simanovski V; Hertz S; Klaric G; Kaizer L; Krzyzanowska MK
    J Oncol Pharm Pract; 2015 Aug; 21(4):249-57. PubMed ID: 24714129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of oral chemotherapy safety and adherence practices of hospitals in Spain.
    Conde-Estévez D; Salas E; Albanell J
    Int J Clin Pharm; 2013 Dec; 35(6):1236-44. PubMed ID: 24129581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving electronic oral chemotherapy prescription: can we build a safer system?
    Weingart SN; Mattsson T; Zhu J; Shulman LN; Hassett M
    J Oncol Pract; 2012 Nov; 8(6):e168-73. PubMed ID: 23598852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary Optimization of Oral Chemotherapy Delivery at the University of Wisconsin Carbone Cancer Center.
    Mulkerin DL; Bergsbaken JJ; Fischer JA; Mulkerin MJ; Bohler AM; Mably MS
    J Oncol Pract; 2016 Oct; 12(10):e912-e923. PubMed ID: 27858570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current practice patterns for oral chemotherapy: results of a national survey.
    Roop JC; Wu HS
    Oncol Nurs Forum; 2014 Mar; 41(2):185-94. PubMed ID: 24370897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the practice of prescribing oral chemotherapy type "Capecitabine" by medical oncologist: A first study from Morocco].
    Kharmoum S; Najdi A; Rahhali R; Meliani M; Boutayeb S; Mrabti H; El Ghissassi I; Afqir S; Mellas N; Ichou M; El M'Rabet FZ; Errihani H
    Bull Cancer; 2021 Oct; 108(10):940-947. PubMed ID: 34281729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ReCAP: Comparison of Independent Error Checks for Oral Versus Intravenous Chemotherapy.
    Griffin MC; Gilbert RE; Broadfield LH; Easty AE; Trbovich PL; Griffin MC; Gilbert RE; Broadfield LH; Easty AE; Trbovich PL
    J Oncol Pract; 2016 Feb; 12(2):168-9; e180-7. PubMed ID: 26420888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer.
    Sommers RM; Miller K; Berry DL
    Oncol Nurs Forum; 2012 Jul; 39(4):E373-9. PubMed ID: 22750908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extending the quality and safety agenda from parenteral to oral chemotherapy.
    Krzyzanowska MK; Powis M
    J Oncol Pract; 2015 May; 11(3):198-201. PubMed ID: 25829521
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
    Divakaruni A; Saylor E; Duffy AP
    J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
    Kumar MG; Coughlin C; Bayliss SJ
    Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicians' preferences for prescribing oral and intravenous anticancer drugs: a Discrete Choice Experiment.
    Benjamin L; Cotté FE; Philippe C; Mercier F; Bachelot T; Vidal-Trécan G
    Eur J Cancer; 2012 Apr; 48(6):912-20. PubMed ID: 22033327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
    Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
    Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of current practice with regard to oral care for children being treated for cancer.
    Glenny AM; Gibson F; Auld E; Coulson S; Clarkson JE; Craig JV; Eden OB; Worthington HV; Pizer B;
    Eur J Cancer; 2004 May; 40(8):1217-24. PubMed ID: 15110886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication errors involving oral chemotherapy.
    Weingart SN; Toro J; Spencer J; Duncombe D; Gross A; Bartel S; Miransky J; Partridge A; Shulman LN; Connor M
    Cancer; 2010 May; 116(10):2455-64. PubMed ID: 20225328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A national survey investigating UK prescribers' opinions on chemotherapy dosing and 'dose-banding'.
    Kaestner SA; Sewell GJ
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):320-8. PubMed ID: 19201584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are patients on oral chemotherapy in your practice setting safe?
    Moody M; Jackowski J
    Clin J Oncol Nurs; 2010 Jun; 14(3):339-46. PubMed ID: 20529795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.